Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.
about
Omega-3 fatty acids for depression in adultsSupplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature DataBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewDetection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementationω-3 Fatty acids for major depressive disorder in adults: an abridged Cochrane reviewOmega-3 fatty acid deficient male rats exhibit abnormal behavioral activation in the forced swim test following chronic fluoxetine treatment: association with altered 5-HT1A and alpha2A adrenergic receptor expression.Comments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67.Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.The effect of chronotherapy on depressive symptoms. Evidence-based practiceInflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.Association between dietary patterns and depressive symptoms over time: a 10-year follow-up study of the GAZEL cohort.Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.Markers of Oxidative Stress and Neuroprogression in Depression Disorder.Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.Neuroenhancement of Exposure Therapy in Anxiety Disorders.Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depressionElevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.Polyunsaturated fatty acids moderate the effect of poor sleep on depression riskRole of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.Mood disorders and complementary and alternative medicine: a literature review.Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.Effect of Citalopram in Combination with Omega-3 on Depression in Post-menopausal Women: A Triple Blind Randomized Controlled TrialPolyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder.Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants.G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids.Omega-3 polyunsaturated fatty acids for major depressive disorder.Nutritional strategies for dealing with depression.ω-3 and major depression: a review.Traditional and alternative treatments for depression: implications for migraine management.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?Five potential therapeutic agents as antidepressants: a brief review and future directions.Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.Evidence for Inflammation-Associated Depression.Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical application.Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study.
P2860
Q24187951-D575A09C-175B-4E41-8C8A-9A1D686A7D5CQ26740508-CEB330A7-29D7-45C6-B1C3-4E36659D1607Q26782993-C0F6C2CC-DCAD-4C0F-B4C3-00807B2F4BFEQ28066354-39DE504D-BE4E-4151-9EA4-90FDBFB35CB7Q28076799-FC313FA9-EB4A-40BD-B410-D8D616777D9DQ30569788-CA0D1D11-1632-4A23-8571-736F71B038DDQ31121789-126C50F4-861B-4513-83EA-5B16637A88B0Q33578486-1B4F3677-E897-4A13-A83A-B0E7B58C6350Q33735300-F9FF8925-B883-4AE8-98C2-37C1FFBF2108Q34468355-7D86CACB-B088-46CD-A750-DCEF963630CAQ34516945-5E2FDA2F-8BDB-46C8-B532-665B835B92A8Q34555244-A6E6CA58-C3CF-49CA-BE22-704AE94328CFQ35677056-99AD9692-36FC-45E5-81EC-C143221E2B58Q35901561-1867343B-71FB-4468-824B-E4BDEC332ABEQ35985350-042BA7B3-673C-42F5-9E98-C2DDEA60276DQ36279126-A80058F0-79D5-4B4B-BDD5-CB7772D3A7DCQ36502629-D5E9E125-73BA-4D15-96E9-8BF569157BB9Q36593835-53D4AF11-CD36-422C-83DB-C1318B5146A3Q36642579-0B0F8E09-3B92-408F-A806-39F7DB082054Q36773267-3E8E4670-DBF9-497A-BF43-A7D1E2100BDFQ36863056-70D4125E-59BA-453D-BB60-18788FA1467CQ36915538-A7F0FD9C-6433-4D02-9AF2-471578218913Q37089253-F279EB3A-72EE-441C-9FC0-B139768A97FFQ37353739-10F1B72A-0874-4CE8-860A-A6C07E712A1BQ37435617-A1EC2022-A6A3-4ACF-886C-F810B05E5790Q37640767-A1CD9E7C-91B4-4A68-906C-21F4D51612C2Q37720606-C78220BE-3A46-45A7-8287-1C959A9878BBQ37729874-EDBD6C1B-E644-4F4D-8B1D-94C436F6D940Q38097891-E4351F43-A976-44F2-A45A-329FA1800896Q38148244-B15A08E2-241A-469F-A242-E900A13D3159Q38155089-591578C6-C5AC-4E4E-9456-6F4B3550ACCCQ38241706-306918DA-287A-407F-9068-F1BC4B7BECBAQ38341758-2560BAF2-3DF0-4AC7-94E4-6C4BB9F34EBEQ38378743-2A1D8C72-A042-45E7-BE82-A0A9AA6D704BQ38574831-6DE9B33F-B36B-4CA0-B405-156CBBE9DEA8Q38657429-52129D4D-1B10-435B-89A3-755939285566Q38808320-C05A7608-6F8A-47EA-A0C4-EFAFBD964C68Q38843528-9D6ACF64-ABEE-4047-881E-416DFCFEDDD9Q39077270-3E2A43DD-8DAA-425D-9C9C-1B37FD327477Q40963212-92770977-DCAE-4277-9924-0334240BFE3E
P2860
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Omega-3 fatty acid augmentatio ...... ith major depressive disorder.
@ast
Omega-3 fatty acid augmentatio ...... ith major depressive disorder.
@en
type
label
Omega-3 fatty acid augmentatio ...... ith major depressive disorder.
@ast
Omega-3 fatty acid augmentatio ...... ith major depressive disorder.
@en
prefLabel
Omega-3 fatty acid augmentatio ...... ith major depressive disorder.
@ast
Omega-3 fatty acid augmentatio ...... ith major depressive disorder.
@en
P2093
P2860
P1476
Omega-3 fatty acid augmentatio ...... with major depressive disorder
@en
P2093
Lev Gertsik
Mark Hyman Rapaport
Russell E Poland
P2860
P356
10.1097/JCP.0B013E31823F3B5F
P407
P577
2012-02-01T00:00:00Z